Sharifkashani, S., Bafrani, M. A., Khaboushan, A. S., Pirzadeh, M., Kheirandish, A., Yavarpour_Bali, H., . . . Rezaei, N. (2020). Angiotensin-converting enzyme 2 (ACE2) receptor and SARS-CoV-2: Potential therapeutic targeting. European journal of pharmacology, 884, 173455. https://doi.org/10.1016/j.ejphar.2020.173455
Citácia podle Chicago (17th ed.)Sharifkashani, Sourena, Melika Arab Bafrani, Alireza Soltani Khaboushan, Marzieh Pirzadeh, Ali Kheirandish, Hanie Yavarpour_Bali, Amirhossein Hessami, Amene Saghazadeh, a Nima Rezaei. "Angiotensin-converting Enzyme 2 (ACE2) Receptor and SARS-CoV-2: Potential Therapeutic Targeting." European Journal of Pharmacology 884 (2020): 173455. https://doi.org/10.1016/j.ejphar.2020.173455.
Citácia podľa MLA (8th ed.)Sharifkashani, Sourena, et al. "Angiotensin-converting Enzyme 2 (ACE2) Receptor and SARS-CoV-2: Potential Therapeutic Targeting." European Journal of Pharmacology, vol. 884, 2020, p. 173455, https://doi.org/10.1016/j.ejphar.2020.173455.